# Braeburn Pharmaceuticals, Inc. — Form D

Braeburn Pharmaceuticals, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-19. The offering totals $110.0M, of which $110.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-01-19
- Form: D
- Accession: 0001140361-18-002621
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $110.0M
- Amount sold: $110.0M
- Investors: 8
- Date of first sale: 2018-01-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-303731

## Issuer

- Name: Braeburn Pharmaceuticals, Inc.
- CIK: 0001688765
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 47 HULFISH STREET, PRINCETON, NJ, 08542
- Phone: 609-751-5375

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Jeffrey L Berkowitz | Director | Coconut Grove, FL |
| Michael Derkacz | Director | Princeton, NJ |
| Seth L Harrison, M.D. | Director | Princeton, NJ |
| Argeris L Karabelas, Ph.D. | Director | Princeton, NJ |
| Patrick L Kennedy | Director | Princeton, NJ |
| Dennis H Langer, J. D., M.D. | Director | Princeton, NJ |
| Brian H Markison | Director | Princeton, NJ |
| Michael Derkacz | Executive Officer | Princeton, NJ |
| Seth L Harrison, M.D. | Executive Officer | Princeton, NJ |
| David J McIntyre | Executive Officer | Princeton, NJ |
| Asher M Rubin | Executive Officer | San Diego, CA |

## More

- [CIK 1688765 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1688765&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-18-002621.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.